Milestone Pharmaceuticals to Present Data on CARDAMYST™ (etripamil) Nasal Spray at the 2026 American College of Cardiology Annual Scientific Session
Go back to Milestone Pharmaceuticals to Present Data on CARDAMYST™ (etripamil) Nasal Spray at the 2026 American College of Cardiology Annual Scientific Session| (NASDAQ: MIST) | Delayed: 1.24 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.24 | 52 Week High | $ | |||
| Open | $0.00 | 52 Week Low | $ | |||
| Day High | $1.24 | P/E | N/A | |||
| Day Low | $1.24 | EPS | $ | |||
| Volume | 0 | |||||
